Team:Calgary/28 May 2009
From 2009.igem.org
(16 intermediate revisions not shown) | |||
Line 80: | Line 80: | ||
</div> | </div> | ||
<br> | <br> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
</html> | </html> | ||
- | { | + | {{Template:CalgaryNotebook}} |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
<html> | <html> | ||
<center> | <center> | ||
Line 173: | Line 128: | ||
</td> | </td> | ||
</tr> | </tr> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
<tr> | <tr> | ||
Line 243: | Line 171: | ||
*Results: Sequencing came back and results indicated that the gene if interest, ''LuxO''D47E was not in the psB1AC3 vector. We will have to go back to the gene in the pCR2.1-TOPO vector and try to get it into the psB1AC3 vector. | *Results: Sequencing came back and results indicated that the gene if interest, ''LuxO''D47E was not in the psB1AC3 vector. We will have to go back to the gene in the pCR2.1-TOPO vector and try to get it into the psB1AC3 vector. | ||
- | + | [[Image:2009.05.28.D47E BBkVer RD+PCR.tif|700px]] | |
<html> | <html> | ||
Line 264: | Line 192: | ||
<br> | <br> | ||
<div class="heading"> | <div class="heading"> | ||
- | + | Ethics paper | |
</div> | </div> | ||
<br> | <br> | ||
<div class="desc"> | <div class="desc"> | ||
</html> | </html> | ||
- | + | Today I helped made our ethics paper handout that we will present the ethics workshop tomorrow. I also made follow up calls to a couple of R&D and O&G development companies. | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
<html> | <html> | ||
Line 316: | Line 218: | ||
<br> | <br> | ||
<div class="heading"> | <div class="heading"> | ||
- | + | Sequencing <i>luxOU</i> with VF1 and VF2. | |
</div> | </div> | ||
<br> | <br> | ||
<div class="desc"> | <div class="desc"> | ||
</html> | </html> | ||
- | + | *luxOU plasmid DNA was sent to the University of Calgary DNA Sequencing Facility for sequencing. | |
<html> | <html> | ||
Line 342: | Line 244: | ||
<br> | <br> | ||
<div class="heading"> | <div class="heading"> | ||
- | + | Send LuxO D47A in psB1AC3 Colony 2 to get sequenced | |
</div> | </div> | ||
<br> | <br> | ||
<div class="desc"> | <div class="desc"> | ||
</html> | </html> | ||
- | + | Although RD and PCR are effective means of verifying the presence of a sequence of DNA, the gold standard for verification is DNA sequencing. LuxO D47A in psB1AC3 Colony 2 was sent to the University of Calgary DNA Sequencing Facility (University Core DNA Services, Calgary, Alberta, Canada). Primers used were VF2 (anneals near the BBK prefix on the BBK vector - used as a forward primer) and VF1 (anneals near the BBK suffix on the BBK vector - used as a reverse primer). The template was prepared such that there was 100ng/1kb of DNA (gene of interest + vector). | |
+ | <br> | ||
+ | <br> | ||
+ | After analyzing the sequencing results, it was evident that luxO D47A was absent from the psB1AC3 vector. | ||
<html> | <html> | ||
Line 368: | Line 273: | ||
<br> | <br> | ||
<div class="heading"> | <div class="heading"> | ||
- | + | Continuing to Discover | |
</div> | </div> | ||
<br> | <br> | ||
<div class="desc"> | <div class="desc"> | ||
</html> | </html> | ||
- | + | This week, the island has finished processing, but we do not have permission to build yet so our second life team continues to attempt to obtain a competent understanding of manipulating objects within the various public sandboxes, mainly from the Knights Bishop public group sandbox. | |
+ | <br> | ||
+ | <br> | ||
+ | I also experimented with the manipulation of avatars: | ||
+ | |||
+ | Skins, which are skins worn over the avatars shaped in world by the sliders, are made in any raster based image editor capable of producing .tga files, Photoshop, Paintshop Pro, GIMP being the big ones. The skins are then uploaded and worn. Using sculpted prims (sculpties) seems to be the most promising and flexible method to manipulate an avatar’s look. I also had to do a survey to obtain $150 LD. | ||
<html> | <html> | ||
Line 422: | Line 332: | ||
<br> | <br> | ||
<div class="heading"> | <div class="heading"> | ||
- | + | More building in Second Life | |
</div> | </div> | ||
<br> | <br> | ||
<div class="desc"> | <div class="desc"> | ||
</html> | </html> | ||
- | + | While waiting for us to get the ability to script/build on our island, we continued in Kings Bishop. We played with a 'door' script in order to make fridges, waterbaths, and other equipment with the ability to be opened, making them more realistic. Also, with our idea to make floating spheres that people could do the biobrick simulator in, I started learning the scripts for teleportation in order for people to get in to the spheres. Also built these spheres. | |
- | + | ||
<html> | <html> | ||
+ | <br> | ||
</div> | </div> | ||
</td> | </td> | ||
Line 439: | Line 349: | ||
</tr> | </tr> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
<tr> | <tr> | ||
Line 474: | Line 359: | ||
<br> | <br> | ||
<div class="heading"> | <div class="heading"> | ||
- | + | Marketing | |
</div> | </div> | ||
<br> | <br> | ||
<div class="desc"> | <div class="desc"> | ||
</html> | </html> | ||
- | + | I spoke to the team about logos. We discussed logo ideas and designs. Also, I contacted the Gauntlet (U of C campus newsletter) about publishing a story on iGEM. I spoke to one of the journalists and scheduled a meeting to interview some of my teammates. | |
<html> | <html> | ||
Line 493: | Line 378: | ||
<tr> | <tr> | ||
<td> | <td> | ||
- | <a name=" | + | <a name="Vicki"></a> |
<br> | <br> | ||
<div class="heading"> | <div class="heading"> | ||
- | + | VICKI | |
</div> | </div> | ||
<br> | <br> | ||
<div class="heading"> | <div class="heading"> | ||
- | + | Gel electrophoresis of PCR and restriction digest products from yesterday | |
</div> | </div> | ||
<br> | <br> | ||
<div class="desc"> | <div class="desc"> | ||
</html> | </html> | ||
- | + | <b>Purpose:</b><br> To analyse the PCR and restriction digest products from yesterday by running them on the gel. This will show: | |
+ | *Whether or not the products are free of DNA contamination | ||
+ | *Whether or not they actually contain LuxPQ BBk (or LuxPQ TOPO) – note that sequencing is the only way to confirm this, but this will help us eliminate products that clearly do not contain the gene of interest | ||
- | < | + | <b>Materials and methods:</b><br> |
- | </ | + | *Preparation. |
- | < | + | **Salvaging the restriction digests, which were hastily left overnight at room temperature and with no orange dye to stop the reaction. This was addressed today, when 4uL of orange dye were introduced to the 20 uL of restriction digest tube contents to deactivate the NotI restriction enzymes. 16 uL of ddHOH were added to bring the total tube volume up to 40 uL |
- | + | **Introducing a negative control. Stock LuxPQ BBk (of the uncut variety) will produce a distinct band on the gel around 7500 bp (accounting for the psB1AC3 plasmid and the LuxPQ gene), with fluctuations in levels based on the degree of coiling. Accordingly, if the NotI restriction digests did not actually digest, the digest lanes will resemble this control. This tube included 2uL of DNA, 1 uL of dye and 7 uL ddHOH | |
+ | **PCR products to evaluate specificity. If there are significant genetic mutations in the BBk sample, the primers will either not anneal at all (resulting in no PCR product) or anneal but give a product that is of a different size (if the mutations are beyond the primer domain). | ||
+ | *Gel set-up | ||
+ | **A 0.7% agarose gel was made. 10 uL of the aforementioned cocktails were loaded into each well, with the well key included in the results picture. Voltage was set at 90V and left to run for 50 minutes. A GenRuler 1 kb Plus DNA Ladder was run in parallel to provide size calibrations for our results. | ||
- | < | + | <b>Results:</b> |
- | + | <br><br> | |
- | </ | + | <center> |
- | + | [[Image:2009.05.28.LuxPQ.BBKVer.RD.PCR.jpg|700px]] | |
- | + | </center> | |
- | + | ||
- | + | ||
- | + | ||
- | <br> | + | |
- | + | ||
- | + | ||
- | + | ||
- | <br> | + | |
- | < | + | |
- | + | ||
- | </ | + | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
<html> | <html> |
Latest revision as of 03:03, 19 October 2009
CAROL
Modeling Readings Continued
LuxCDABE-M-F:CCATTAATGAATTGCCGGATAATCTGGATTTTGAAGGCC LuxCDABE-M-R:GGCCTTCAAAATCCAGATTATCCGGCAATTCATTAATGG
|
EMILY
Sequencing of LuxOD47E in psB1AC3
File:2009.05.28.D47E BBkVer RD+PCR.tif
|
FAHD
Ethics paper
Today I helped made our ethics paper handout that we will present the ethics workshop tomorrow. I also made follow up calls to a couple of R&D and O&G development companies.
|
JAMIE
Sequencing luxOU with VF1 and VF2.
|
JEREMY
Send LuxO D47A in psB1AC3 Colony 2 to get sequenced
Although RD and PCR are effective means of verifying the presence of a sequence of DNA, the gold standard for verification is DNA sequencing. LuxO D47A in psB1AC3 Colony 2 was sent to the University of Calgary DNA Sequencing Facility (University Core DNA Services, Calgary, Alberta, Canada). Primers used were VF2 (anneals near the BBK prefix on the BBK vector - used as a forward primer) and VF1 (anneals near the BBK suffix on the BBK vector - used as a reverse primer). The template was prepared such that there was 100ng/1kb of DNA (gene of interest + vector).
After analyzing the sequencing results, it was evident that luxO D47A was absent from the psB1AC3 vector.
|
KATIE
Continuing to Discover
This week, the island has finished processing, but we do not have permission to build yet so our second life team continues to attempt to obtain a competent understanding of manipulating objects within the various public sandboxes, mainly from the Knights Bishop public group sandbox.
I also experimented with the manipulation of avatars: Skins, which are skins worn over the avatars shaped in world by the sliders, are made in any raster based image editor capable of producing .tga files, Photoshop, Paintshop Pro, GIMP being the big ones. The skins are then uploaded and worn. Using sculpted prims (sculpties) seems to be the most promising and flexible method to manipulate an avatar’s look. I also had to do a survey to obtain $150 LD.
|
KEVIN
Matlab and symbiology
Familiarizing with the matlab program provided by MathWorks, and its biological tool called Symbiology.
No experiments were done on this day.
|
MANDY
More building in Second Life
While waiting for us to get the ability to script/build on our island, we continued in Kings Bishop. We played with a 'door' script in order to make fridges, waterbaths, and other equipment with the ability to be opened, making them more realistic. Also, with our idea to make floating spheres that people could do the biobrick simulator in, I started learning the scripts for teleportation in order for people to get in to the spheres. Also built these spheres.
|
PRIMA
Marketing
I spoke to the team about logos. We discussed logo ideas and designs. Also, I contacted the Gauntlet (U of C campus newsletter) about publishing a story on iGEM. I spoke to one of the journalists and scheduled a meeting to interview some of my teammates.
|
VICKI
Gel electrophoresis of PCR and restriction digest products from yesterday
Purpose:
To analyse the PCR and restriction digest products from yesterday by running them on the gel. This will show:
Materials and methods:
Results:
|